1. Home
  2. INO vs SBI Comparison

INO vs SBI Comparison

Compare INO & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

118.9M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Intermediate Muni Fund Inc

SBI

Western Asset Intermediate Muni Fund Inc

HOLD

Current Price

$7.00

Market Cap

108.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INO
SBI
Founded
1979
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
118.9M
108.9M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
INO
SBI
Price
$1.18
$7.00
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $6.75
N/A
AVG Volume (30 Days)
★ 2.8M
50.0K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
★ 4.52%
EPS Growth
★ 54.18
N/A
EPS
N/A
★ N/A
Revenue
★ $42,220,086.00
N/A
Revenue This Year
$20,156.19
N/A
Revenue Next Year
$421.95
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 19.37
N/A
52 Week Low
$0.56
$7.00
52 Week High
$2.72
$8.01

Technical Indicators

Market Signals
Indicator
INO
SBI
Relative Strength Index (RSI) 47.21 14.96
Support Level $1.06 N/A
Resistance Level $1.24 $7.89
Average True Range (ATR) 0.08 0.09
MACD -0.02 -0.04
Stochastic Oscillator 27.03 3.33

Price Performance

Historical Comparison
INO
SBI

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager.

Share on Social Networks: